載入...
Pharmacologic Therapies for Idiopathic Pulmonary Fibrosis, Past and Future
Idiopathic pulmonary fibrosis (IPF) is a severe, progressive fibrotic disease of the lung of unknown etiology that affects approximately 150,000 patients in the United States. It carries a median survival of two to three years, but clinical course can vary markedly from patient to patient. There has...
Na minha lista:
| 發表在: | Ann Med |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638420/ https://ncbi.nlm.nih.gov/pubmed/25613169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.991751 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|